XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5

The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024

ISIN Name
US87166L2097 SYNLOGIC INC. DL-,001
US87250W3016 BAIYU HOLD.I. NEW DL-,001
US88362L2097 THERMOGENESIS H.INC. NEW
US8902608541 TONIX PHA.NEW2023 DL-,001
US89846A4058 TRXADE HEALTH DL-,0001
US9221073052 VAPOTHERM INC. COM NEW
US92332W2044 VENUS CONCEPT INC. -,0001
US92337U2033 VERB TE.CO.INC DL-,0001
US92823T2078 VIRNETX HLG CP.NEW DL-001
US92836Y4098 VISLI.T.INC NEW DL-,00001
US9840156023 XENETIC BIOSCIE DL-,001
US98420U8027 XWELL INC.
US98880R2085 ZW DATA ACT.T.NEW DL-,001
VGG569812057 LUOKUNG TECH.CORP. DL-,30
VGG885761061 THUNDERBIRD RESORTS INC.

6 Richtige für 2025

Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!

Hier klicken

Zeit	Aktuelle Nachrichten
26.08.	Agility Real Estate Inc.: Agility asset sale, escrow settlement, debt paydown, 50:1 reverse split and officer share purchase		TAMPA, FL, UNITED STATES OF AMERICA, August 26, 2024 -- Agility Real Estate Inc. ("Agility") (Euronext: AGIL) is pleased to announce the following material events: 1. ASSET SALE & ESCROW SETTLEMENT:... ► Artikel lesen
13.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5		The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS87166L2097 SYNLOGIC... ► Artikel lesen

Zeit

Aktuelle Nachrichten

26.08.

Agility Real Estate Inc.: Agility asset sale, escrow settlement, debt paydown, 50:1 reverse split and officer share purchase

TAMPA, FL, UNITED STATES OF AMERICA, August 26, 2024 -- Agility Real Estate Inc. ("Agility") (Euronext: AGIL) is pleased to announce the following material events: 1. ASSET SALE & ESCROW SETTLEMENT:...
► Artikel lesen

13.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5

Zeit	Aktuelle Nachrichten
Mo	BAIYU Holdings, Inc. - 8-K, Current Report
04.12.	BAIYU Holdings, Inc. - 8-K, Current Report
22.11.	BAIYU Holdings, Inc. - 8-K, Current Report
13.11.	BAIYU Holdings, Inc. - 10-Q, Quarterly Report
30.10.	BAIYU Holdings unterzeichnet Vertrag zur Stärkung der Lithiumbatterie-Lieferkette

Zeit

Aktuelle Nachrichten

BAIYU Holdings, Inc. - 8-K, Current Report

04.12.

BAIYU Holdings, Inc. - 8-K, Current Report

22.11.

BAIYU Holdings, Inc. - 8-K, Current Report

13.11.

BAIYU Holdings, Inc. - 10-Q, Quarterly Report

30.10.

BAIYU Holdings unterzeichnet Vertrag zur Stärkung der Lithiumbatterie-Lieferkette

Zeit	Aktuelle Nachrichten
17.12.	LKCO-Aktie erreicht 52-Wochen-Tief bei 1,57 US-Dollar
17.12.	LKCO stock touches 52-week low at $1.57 amid market shifts
05.11.	LKCO stock touches 52-week low at $1.73 amid market challenges
05.11.	LKCO-Aktie erreicht 52-Wochen-Tief bei 1,73 US-Dollar
25.10.	Luokung receives additional non-compliance notice from Nasdaq

Zeit

Aktuelle Nachrichten

17.12.

LKCO-Aktie erreicht 52-Wochen-Tief bei 1,57 US-Dollar

17.12.

LKCO stock touches 52-week low at $1.57 amid market shifts

05.11.

LKCO stock touches 52-week low at $1.73 amid market challenges

05.11.

LKCO-Aktie erreicht 52-Wochen-Tief bei 1,73 US-Dollar

25.10.

Luokung receives additional non-compliance notice from Nasdaq

Zeit	Aktuelle Nachrichten
10.12.	Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
04.12.	Scienture Holdings files for secondary stock offering
04.12.	Scienture Holdings, Inc. - S-1, General form for registration of securities
26.11.	Scienture announces private placement of $3M of 10% secured convertible debentures
26.11.	Scienture Holdings, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

10.12.

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041

04.12.

Scienture Holdings files for secondary stock offering

04.12.

Scienture Holdings, Inc. - S-1, General form for registration of securities

26.11.

Scienture announces private placement of $3M of 10% secured convertible debentures

26.11.

Scienture Holdings, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
12.11.	Synlogic GAAP EPS of -$0.01
12.11.	Synlogic, Inc.: Synlogic Reports Third Quarter 2024 Financial Results	WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported... ► Artikel lesen
12.11.	SYNLOGIC, INC. - S-8, Securities to be offered to employees in employee benefit plans
12.11.	SYNLOGIC, INC. - 10-Q, Quarterly Report
12.08.	SYBX stock touches 52-week low at $1.3 amid market challenges

Zeit

Aktuelle Nachrichten

12.11.

Synlogic GAAP EPS of -$0.01

12.11.

Synlogic, Inc.: Synlogic Reports Third Quarter 2024 Financial Results

WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
► Artikel lesen

12.11.

SYNLOGIC, INC. - S-8, Securities to be offered to employees in employee benefit plans

12.11.

SYNLOGIC, INC. - 10-Q, Quarterly Report

12.08.

SYBX stock touches 52-week low at $1.3 amid market challenges

Zeit	Aktuelle Nachrichten
15.08.	ThermoGenesis Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB
06.08.	ThermoGenesis Holdings, Inc. - 8-K, Current Report
16.07.	ThermoGenesis Holdings, Inc. - 8-K, Current Report
13.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5	The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS87166L2097 SYNLOGIC... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.08.

ThermoGenesis Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB

06.08.

ThermoGenesis Holdings, Inc. - 8-K, Current Report

16.07.

ThermoGenesis Holdings, Inc. - 8-K, Current Report

13.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5

Zeit	Aktuelle Nachrichten
Mo	Tonix gets FDA target action date for TNX-102 SL
Mo	FDA legt Prüfungstermin für Tonix' Fibromyalgie-Medikament fest
Mo	FDA sets review goal date for Tonix fibromyalgia drug
Mo	Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia	Tonix received FDA's Day 74 Letter granting TNX-102 SL a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025 TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast... ► Artikel lesen
17.12.	What's Going On With Tonix Pharmaceuticals Stock Today?

Zeit

Aktuelle Nachrichten

Tonix gets FDA target action date for TNX-102 SL

FDA legt Prüfungstermin für Tonix' Fibromyalgie-Medikament fest

FDA sets review goal date for Tonix fibromyalgia drug

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Tonix received FDA's Day 74 Letter granting TNX-102 SL a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025 TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast...
► Artikel lesen

17.12.

What's Going On With Tonix Pharmaceuticals Stock Today?

Zeit	Aktuelle Nachrichten
25.09.	VAPOTHERM INC - 15-12G, Securities registration termination
24.09.	Vapotherm director James Liken sells $15,956 in stock, disposes of additional $119,481 worth
20.09.	Vapotherm, Inc.: Vapotherm Announces Closing of Merger	EXETER, N.H., Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and... ► Artikel lesen
19.09.	VAPOTHERM INC - 8-K, Current Report
13.08.	Vapotherm GAAP EPS of -$2.22, revenue of $16.9M

Zeit

Aktuelle Nachrichten

25.09.

VAPOTHERM INC - 15-12G, Securities registration termination

24.09.

Vapotherm director James Liken sells $15,956 in stock, disposes of additional $119,481 worth

20.09.

Vapotherm, Inc.: Vapotherm Announces Closing of Merger

EXETER, N.H., Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and...
► Artikel lesen

19.09.

VAPOTHERM INC - 8-K, Current Report

13.08.

Vapotherm GAAP EPS of -$2.22, revenue of $16.9M

Zeit	Aktuelle Nachrichten
04.12.	Venus-Concept-Direktor Anthony Natale veräußert Aktien im Wert von 13.193 US-Dollar
03.12.	Venus Concept Inc. - 8-K, Current Report
13.11.	Venus Concept misses top-line and bottom-line estimates; initiates Q424 outlook
13.11.	Venus Concept Inc.: Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results	TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen
13.11.	Venus Concept Inc. - 10-Q, Quarterly Report

Zeit

Aktuelle Nachrichten

04.12.

Venus-Concept-Direktor Anthony Natale veräußert Aktien im Wert von 13.193 US-Dollar

03.12.

Venus Concept Inc. - 8-K, Current Report

13.11.

Venus Concept misses top-line and bottom-line estimates; initiates Q424 outlook

13.11.

Venus Concept Inc.: Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
► Artikel lesen

13.11.

Venus Concept Inc. - 10-Q, Quarterly Report

Zeit	Aktuelle Nachrichten
22.11.	Verb Technology Company, Inc.: VERB CEO to Participate in Nasdaq's 'Ring in the Races' Closing Bell Ceremony Live at F1 in Las Vegas
12.11.	Verb Technology reports Q3 results
05.11.	Verb Technology Company, Inc. - 10-Q, Quarterly Report
28.10.	Verb Technology erfüllt wieder Nasdaq-Anforderungen für Aktienkurs
28.10.	Verb Technology Company, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

22.11.

Verb Technology Company, Inc.: VERB CEO to Participate in Nasdaq's 'Ring in the Races' Closing Bell Ceremony Live at F1 in Las Vegas

12.11.

Verb Technology reports Q3 results

05.11.

Verb Technology Company, Inc. - 10-Q, Quarterly Report

28.10.

Verb Technology erfüllt wieder Nasdaq-Anforderungen für Aktienkurs

28.10.

Verb Technology Company, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
09.12.	VirnetX names John Jamison as CTO
09.12.	VirnetX Holding Names John Anthony Jamison CTO, Succeeding Victor Larson
09.12.	VirnetX Holding Corporation: VirnetX Announces New Chief Technical Officer	ZEPHYR COVE, Nev., Dec. 9, 2024 /PRNewswire/ -- VirnetX Holding Corporation (NYSE: VHC) today announced that it has hired Dr. John Anthony Jamison as new VirnetX... ► Artikel lesen
13.11.	VirnetX Holding Corp - 10-Q, Quarterly Report
04.09.	VirnetX Holding Corp - 8-K, Current Report

Zeit

Aktuelle Nachrichten

09.12.

VirnetX names John Jamison as CTO

09.12.

VirnetX Holding Names John Anthony Jamison CTO, Succeeding Victor Larson

09.12.

VirnetX Holding Corporation: VirnetX Announces New Chief Technical Officer

ZEPHYR COVE, Nev., Dec. 9, 2024 /PRNewswire/ -- VirnetX Holding Corporation (NYSE: VHC) today announced that it has hired Dr. John Anthony Jamison as new VirnetX...
► Artikel lesen

13.11.

VirnetX Holding Corp - 10-Q, Quarterly Report

04.09.

VirnetX Holding Corp - 8-K, Current Report

Zeit	Aktuelle Nachrichten
04.12.	Vislink Technologies, Inc.: Vislink Introduces DragonFly V 5G Miniature Transmitter: Redefining Portable Live Video Streaming
14.11.	Vislink Technologies, Inc. - 10-Q, Quarterly Report
14.11.	Vislink Technologies GAAP EPS of -$1.22 misses by $0.49, revenue of $7.07M misses by $1.4M
14.11.	Vislink Technologies, Inc.: Vislink Reports Third Quarter 2024 Financial and Operational Results	Year-to-Date Revenue Increased 26% Year-Over-Year to $24.4 Million New ERP Implementation Insights lead to Restructuring Initiative Expected to Achieve Over $6 Million in Annualized Cost Savings... ► Artikel lesen
14.11.	Vislink Technologies, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

04.12.

Vislink Technologies, Inc.: Vislink Introduces DragonFly V 5G Miniature Transmitter: Redefining Portable Live Video Streaming

14.11.

Vislink Technologies, Inc. - 10-Q, Quarterly Report

14.11.

Vislink Technologies GAAP EPS of -$1.22 misses by $0.49, revenue of $7.07M misses by $1.4M

14.11.

Vislink Technologies, Inc.: Vislink Reports Third Quarter 2024 Financial and Operational Results

Year-to-Date Revenue Increased 26% Year-Over-Year to $24.4 Million New ERP Implementation Insights lead to Restructuring Initiative Expected to Achieve Over $6 Million in Annualized Cost Savings...
► Artikel lesen

14.11.

Vislink Technologies, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
17.12.	Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment	Reid Bissonnette, Ph.D, Executive Consultant for Translational Research and Development at Xenetic, discusses extension of its Research Agreement with the University of Virginia for the advancement... ► Artikel lesen
16.12.	Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform	Company continuing to advance DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / December 16, 2024 / Xenetic Biosciences, Inc.... ► Artikel lesen
13.12.	Xenetic Biosciences, Inc. - 8-K, Current Report
05.12.	Xenetic und PeriNess kooperieren bei Krebsbehandlungsstudien
05.12.	Xenetic and PeriNess partner for cancer treatment trials

Zeit

Aktuelle Nachrichten

17.12.

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

Reid Bissonnette, Ph.D, Executive Consultant for Translational Research and Development at Xenetic, discusses extension of its Research Agreement with the University of Virginia for the advancement...
► Artikel lesen

16.12.

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

Company continuing to advance DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / December 16, 2024 / Xenetic Biosciences, Inc....
► Artikel lesen

13.12.

Xenetic Biosciences, Inc. - 8-K, Current Report

05.12.

Xenetic und PeriNess kooperieren bei Krebsbehandlungsstudien

05.12.

Xenetic and PeriNess partner for cancer treatment trials

Zeit	Aktuelle Nachrichten
05.12.	XWELL, Inc.: Open Letter to XWELL Shareholders from CEO Ezra Ernst	NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that the Company's Chief... ► Artikel lesen
05.12.	XWELL, Inc. - 8-K, Current Report
14.11.	XWELL reports Q3 results
14.11.	XWELL, Inc. Reports Third Quarter 2024 Results	NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter... ► Artikel lesen
14.11.	XWELL, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

05.12.

XWELL, Inc.: Open Letter to XWELL Shareholders from CEO Ezra Ernst

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that the Company's Chief...
► Artikel lesen

05.12.

XWELL, Inc. - 8-K, Current Report

14.11.

XWELL reports Q3 results

14.11.

XWELL, Inc. Reports Third Quarter 2024 Results

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter...
► Artikel lesen

14.11.

XWELL, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
13.12.	ZW Data Action Technologies Inc. - 8-K, Current Report
19.11.	ZW Data Action Technologies Inc. - 10-Q, Quarterly Report
04.10.	ZW Data Action Technologies Inc. - 8-K, Current Report
27.09.	ZW Data Action Technologies schließt Vereinbarung mit Direktor
25.09.	ZW Data enacts reverse stock split to meet Nasdaq requirements

Zeit

Aktuelle Nachrichten

13.12.

ZW Data Action Technologies Inc. - 8-K, Current Report

19.11.

ZW Data Action Technologies Inc. - 10-Q, Quarterly Report

04.10.

ZW Data Action Technologies Inc. - 8-K, Current Report

27.09.

ZW Data Action Technologies schließt Vereinbarung mit Direktor

25.09.

ZW Data enacts reverse stock split to meet Nasdaq requirements

Unternehmen / Aktien	Kurs	%
AGILITY REAL ESTATE INC	0,064	0,00 %
BAIYU HOLDINGS INC	0,056	0,00 %
LUOKUNG TECHNOLOGY CORP ADR	1,720	0,00 %
SCIENTURE HOLDINGS INC	7,263	-7,28 %
SYNLOGIC INC	1,400	0,00 %
THERMOGENESIS HOLDINGS INC	0,290	0,00 %
TONIX PHARMACEUTICALS HOLDING CORP	0,388	0,00 %
VAPOTHERM INC	1,130	0,00 %
VENUS CONCEPT INC	0,347	0,00 %
VERB TECHNOLOGY COMPANY INC	6,390	0,00 %
VIRNETX HOLDING CORPORATION	5,150	0,00 %
VISLINK TECHNOLOGIES INC	3,690	0,00 %
XENETIC BIOSCIENCES INC	4,180	0,00 %
XWELL INC	1,580	0,00 %
ZW DATA ACTION TECHNOLOGIES INC	1,950	0,00 %

Unternehmen / Aktien

Kurs

AGILITY REAL ESTATE INC

0,064

0,00 %

BAIYU HOLDINGS INC

0,056

0,00 %

LUOKUNG TECHNOLOGY CORP ADR

1,720

0,00 %

SCIENTURE HOLDINGS INC